Answers are grounded in this paper and cite their sources.
Metabolite profiling in large prospective cohorts identified phenylalanine, monounsaturated fatty acids, and polyunsaturated fatty acids as biomarkers for cardiovascular risk. This study substantiates the value of high-throughput metabolomics for biomarker discovery and improved risk assessment.
No takes yet. Share an insight, caveat, or question.
Würtz et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: